Microbio Co., Ltd. applies symbiotic fermentation technology to develop botanical drug. The Company's products include clinically proven botanical drugs, pharmaceutically active ingredients, and nutrient supplements.

Announcement For The Board Of Directors'
Resolution To Disposal Of Investment Property To
Related Party

Announcement Of Year 2025q3 Consolidated
Financial Reports Were Approved By The Bod

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Microbio Co Ltd (4128 TT)

Announcement For The Board Of Directors' Resolution To Disposal Of Investment Property To Related Party

Announcement Of Year 2025q3 Consolidated Financial Reports Were Approved By The Bod

Announcement For The Expected Date Of The Board Of Directors Meeting For The Third Quarter Of 2025 Consolidated Financial Report Is 2025/11/11

Announcement Of The Change Of The Internal Audit Officer

Announces The Information About The 1st Online Investor’S Conference Of 2025.

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)